Angina Pectoris, Coronary Disease, Myocardial Ischemia
Conditions
Keywords
Outcomes Assessment, Primary Health Care, Group Process
Brief summary
Data from VA-funded studies and the broader literature indicate that chronic stable angina (CSA) is prevalent, under recognized, under treated and associated with reduced quality of life. There are substantial opportunities for improving care of patients with this debilitating and potentially fatal problem. Because primary care providers manage most patients with CSA, efforts to improve care must necessarily involve the primary care delivery system. C3P is composed of a set of interventions employing a Collaborative Care Team model, which has been shown to be effective in managing other chronic illnesses in the primary care setting.
Detailed description
Objectives of the proposed project are to: 1) ascertain whether a collaborative approach to managing CSA in primary care results in better symptom control and quality of life than routine care; 2) assess whether the practice of providers assigned to the intervention group is more consistent with national clinical practice guidelines than that of control providers; 3) assess satisfaction of both patients and providers with this approach to management; and 4) assess marginal cost-effectiveness.
Interventions
Sponsors
US Department of Veterans Affairs
Study design
Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
Providers: * Staff (MD, PA, NP) or resident (R1, R2) * at least 1 participating patient Patients * assigned to participating provider * diagnosis consistent with IHD * 2 visits in past year * frequent angina symptoms (SAQ freq. score less than 70)
Exclusion criteria
Providers: \- No participating patients Patients: * cognitive impairment (inability to complete questionnaires and phone interviews) * non-participating provider * life expectancy of less than 24 months
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Symptom control, quality of life and satisfaction at one year; improved practitioner compliance with national clinical practice guidelines over the one-year intervention period | — |
Secondary
| Measure | Time frame |
|---|---|
| Marginal cost effectiveness during one-year study period | — |
Countries
United States
Outcome results
None listed